Why you should stop scrolling in the bathroom and the unsavory truth about your phone.

Published Date: 26 Apr 2023

More than 90% of people in the world own or use a mobile phone, and many of us couldn't live without them. We carry them everywhere we go, use them in bed and the bathroom, and for many people, they are the first thing they see in the morning.

Read Full News

Latest News

PAHO Strengthens Ebola Preparedness

The Pan American Health Organization said on Thursday it is stepping up efforts to help ⁠countries across the Americas to strengthen their preparedness for Ebola.

USDA Expects to Contain Screwworm Case in Texas, Rollins Says

U.S. Agriculture Secretary Brooke ⁠Rollins said on Thursday that the USDA believes ⁠it can contain a case of ⁠New World screwworm ‌in Texas, the first case in the state...

Romania Remains Europe’s Measles Hotspot

Romania’s children under 5 are experiencing the worst of Europe’s measles outbreaks. Are new policies sufficient to encourage more childhood vaccinations?

WHO Launches $518 Million Plan to Curb Africa Ebola Outbreak

The World Health Organization chief announced a $518 million six-month joint plan to fight Ebola on Friday, calling ⁠for money and political commitment to halt the spread of...

WHO Says Ebola Response Catching Up as Confirmed DRC Cases Hit 344

The World Health Organization said on Wednesday that the world is "catching up" with the Ebola outbreak in Democratic Republic of Congo, where there ⁠have been 344 confirmed...

Deep Dive: IL Inhibitor and JAK Inhibitor in Atopic Dermatitis

IL-4 and IL-13 drive the inflammation that breaks down the skin barrier and fuels the “atopic march” when atopic dermatitis (AD) progresses to other allergic diseases. Dupilumab blocks signaling through both pathways, delivering disease control that can persist even after treatment discontinuation in some patients.

Todays Updates

Smartphone App Detects Eye Cancers From Photos

A smartphone app that analyzes images of the eye may enable early screening for cancers of the eye surface, flag lesions at high risk for specialist review, and expand access beyond clinics.

Todays Updates

Smartphone App Detects Eye Cancers From Photos

A smartphone app that analyzes images of the eye may enable early screening for cancers of the eye surface, flag lesions at high risk for specialist review, and expand access beyond clinics.

Latest News

The Pan American Health Organization said on Thursday it is stepping up efforts to help ⁠countries across the Americas to strengthen their preparedness for Ebola.

U.S. Agriculture Secretary Brooke ⁠Rollins said on Thursday that the USDA believes ⁠it can contain a case of ⁠New World screwworm ‌in Texas, the first case in the state...

Romania’s children under 5 are experiencing the worst of Europe’s measles outbreaks. Are new policies sufficient to encourage more childhood vaccinations?

The World Health Organization chief announced a $518 million six-month joint plan to fight Ebola on Friday, calling ⁠for money and political commitment to halt the spread of...

The World Health Organization said on Wednesday that the world is "catching up" with the Ebola outbreak in Democratic Republic of Congo, where there ⁠have been 344 confirmed...

IL-4 and IL-13 drive the inflammation that breaks down the skin barrier and fuels the “atopic march” when atopic dermatitis (AD) progresses to other allergic diseases. Dupilumab blocks signaling through both pathways, delivering disease control that can persist even after treatment discontinuation in some patients.

News All Time

Red Cross Mourns Death of Three Volunteers From Ebola

The Red Cross on Saturday paid tribute to three volunteers who ⁠are believed to have died after contracting Ebola while handling bodies.

US Adds Atlanta Area Airport for Ebola Screening, CDC Says

Americans coming back from the Democratic Republic of the Congo, ⁠Uganda or South Sudan now have a second entry point for returning ⁠to the United States, with the CDC on...

US FDA Advisers to Weigh Updating 2026-27 COVID Vaccines for XFG Variant

Advisers to the U.S. Food and Drug Administration will discuss whether COVID-19 vaccines should be updated to target the latest circulating XFG ⁠subvariant for the 2026-27...

Shingles Shot Shows Short-Term Safety in People With HIV

In people living with HIV, the adjuvanted recombinant subunit herpes zoster vaccine shows a favorable short-term safety and tolerability profile.

Inside an African Lab That Helped Crack the Hantavirus Outbreak

(Clarifies status of Istitut Pasteur de Dakar in paragraphs 6, 8-9)

Chikungunya in Pregnancy Raises Infant Hospital Risk

A cohort study of births in Brazil found increased hospitalization risk through age 3 after maternal chikungunya; results inform global surveillance and vaccination strategies.

UK Commits $26.87 Million to Contain Ebola Outbreak in DRC

Britain has allocated up to 20 million pounds ($26.87 million) in ⁠new aid funding to help contain an Ebola outbreak in eastern ⁠Democratic Republic of the Congo, the UK's...

US Working With Small Biotech Firm on Experimental Ebola Treatment, HHS Official Says

U.S. officials are working with Mapp Biopharmaceutical to make an experimental Ebola treatment available for people who may have been exposed to ⁠the virus, an HHS official...

Congenital CMV Linked to Substantial Long-Term Health Issues

An analysis conducted in an integrated healthcare system provided insights into the long-term healthcare burden of cCMV infection.

Why the Test-Negative Design Is Our Most Vital Tool for Vaccine Effectiveness

Dr Daskalakis explains vaccine study designs and how the science of test negative design, a decades-old, tried and true design, is now being called into question.

Test Shortages Slow Fight Against Ebola in Congo, WHO Official Says

Six tons of medical supplies to fight Ebola are set to arrive in the Democratic Republic of Congo on Tuesday, ⁠but limited testing capacity was slowing the response to the...

Bird Flu Found in Polar Bear in Europe for First Time

Bird flu has been detected in a dead polar bear in the ⁠Arctic Svalbard archipelago, the first time the virus has been found in the species in ⁠Europe.

US States Reject Anti-vaccine Bills as Public Health Groups Fight MAHA

Dozens of state anti-vaccine bills backed by "Make America Healthy Again" supporters have failed after public health groups won over Republican state lawmakers, marking a...

Adult Dies of Hantavirus in Colorado, State Health Officials Say

An adult in Colorado has died after a confirmed ⁠case of hantavirus that is not linked to a recent outbreak aboard ⁠a cruise ship in the Atlantic, Colorado Department of...

Britain Gets Experimental Drug From Japan to Bolster Hantavirus Response

Britain has received supplies of the antiviral drug favipiravir from Japan as part of its response to a deadly hantavirus ⁠outbreak linked to the Hondius cruise liner, the...

US Health Department Withdraws Vaccine Advisory Panel Charter

The U.S. health department has withdrawn an April charter renewal for a key vaccine ⁠advisory panel that laid out new membership rules and direction, citing an...

Recommended News For You

Researchers use genomic technology to investigate aggressive skin cancer linked to burn scars

Hydroxyurea Shows Some Benefits in Milder Sickle Cell Disease

According to new studies, some cancer patients can safely forego radiation therapy.

The risk of ovarian cancer is not increased by salpingectomy, according to JAMA.

US Counties Suffered Significantly from a Lack of Psychiatric Care.

Three out of ten breast cancers detected between screenings, study finds

A prostate cancer risk prediction algorithm could help target men at highest risk

Recommended Articles For You

Unlocking the Potential of Immune Checkpoint Inhibitors: A Pioneering Case Series on the Role of Immunotherapy in Microsatellite-Instability-High Colorectal Cancer 

Case Study: Diagnostic and Therapeutic Challenges in Aplastic Anemia Mimicking Hypoplastic Myelodysplastic Syndrome 

Pharmacological Frontier of Precision Oncology, Immunotherapies, and the Evolving Art of Treatment 

Advancing Oncology Careers with Education, Workflow Tools, and Clinical Resources 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

WHO releases new R&D landscape analyses highlighting gaps and inequities in cancer research

2.

AI tool identifies women at high risk of interval breast cancer

3.

For older LBCL patients, Axi-Cel exhibits durable responses and extends overall survival.

4.

The FDA has approved momelotinib for use in myelofibrosis patients who also have anemia.

5.

Kate Middleton Reaches Cancer Treatment Milestone

1.

Unlocking the Mystery of Glanzmann Thrombasthenia: A New Hope for Patients

2.

The Cutting-Edge of Phlebectomy: Redefining Vein Care

3.

From Diagnosis to Recovery: A Comprehensive Guide to Dealing with Cystic Teratoma

4.

Tremelimumab: A Potential Breakthrough in Cancer Treatment

5.

Unveiling the Chadwick Sign: A Revolutionary New Tool for Detecting Early Signs of Cancer

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

International Lung Cancer Congress®

3.

Genito-Urinary Oncology Summit 2026

4.

Future NRG Oncology Meeting

5.

ISMB 2026 (Intelligent Systems for Molecular Biology)

1.

Exploring Potentials of Lorlatinib: The Third Generation ALK-TKI Through CROWN Trial

2.

Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part III

3.

Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Final Discussion

4.

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part III

5.

A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part IV

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot